MRI-guided personalisation of neoadjuvant chemotherapy duration is associated with improved 3-year survival outcomes in patients with stage II-III HER2-positive breast cancer, a new trial reports.

The case emphasizes Bannwarth syndrome as a rare but treatable cause of neurologic deterioration in an older woman receiving surgical cancer care.

A recent UC Santa Cruz study, published in Nature Communications scientific journal, uncovered clues in a decadeslong mystery ...

GLP1-RA use may be linked to improved overall survival, but not improved disease-free survival, in breast cancer survivors, researchers report.

A 2025 scoping review on cancer health literacy in Kenya found that public awareness of available treatment options was ...

Fresh concerns over preventable breast cancer deaths among uninsured women in Barbados have sparked renewed calls for early screening, as a local medical ...

Scientists looking for new ways to tackle hard-to-treat breast cancers turned to an unexpected source: Munronia henryi, a plant known for producing limonoids, a family of complex natural compounds ...

Only 72% of black women were diagnosed with breast cancer at an early stage in Kent and Medway - compared to 85% of white ...

Health minister Ashley Dalton, who has advanced breast cancer, has resigned from her post, saying now is the time for her to make 'reasonable adjustments' to manage her condition ...

Fore Her hosts annual Tea Fore Her ...

After undergoing chemotherapy and treatment, Samantha Smith did not expect that one of the drugs saving her life could later ...

A study reveals 1 in 4 Indian breast cancer patients carry inherited genetic variants beyond known BRCA genes, urging broader testing strategies.